Published: July 11th, 2014
Several studies to date have found that people with type 1 diabetes (T1D) tend to have celiac disease more often than individuals in the general population. Michael Haller, MD, a pediatric endocrinologist at UF Health, told Medscape Medical News in a recent interview that screening every type 1 diabetes patient for the disease presents a unique clinical challenge. Read more.
Published: July 11th, 2014
A new study co-authored by UF diabetes researchers finds that bacteria in the guts of young children with type 1 diabetes are different from those of other kids. The research is helping clarify the importance of healthy gut bacteria development in early childhood and could help lead to novel prevention therapies for people at risk of developing the disease.
Published: July 8th, 2014
In a new five-year study funded by the National Institutes of Health, University of Florida researchers will study the effects of bariatric weight-loss surgery on brain function, thinking, and memory. The cutting-edge research is the latest in a growing movement to explore the potential relationships between type 2 diabetes mellitus and Alzheimer’s disease.
Published: July 5th, 2014
UF Health physician Kenneth Cusi, MD recently gave his perspective on a small new study took the first step to demonstrate a link between non-alcoholic fatty liver disease (NAFLD) and an increased incidence of chronic kidney disease among type 1 diabetes patients. The editorial was published in the online magazine, EndocrineToday.
Published: June 21st, 2014
UF and UF Health faculty, postdoctoral fellows, and graduate students submitted a record number of original research presentations for the American Diabetes Association’s 74th Scientific Sessions held June 13-17, 2014 at the Moscone Center in San Francisco, California. This year’s submissions represent one of the largest showcases of research emanating from UF.
Published: June 13th, 2014
Time spent in sedentary behaviors could affect whether some people develop Type 2 diabetes later in life. Data from the Women’s Health Initiative shows postmenopausal women who sat more than 16 hours during their waking day had the highest risk of developing diabetes. The UF analysis also found that the high risk of diabetes remained even if they otherwise exercised five days a week, 30 minutes per day. Read more.
Published: June 2nd, 2014
Researchers in the UF Department of Pathology, Immunology, and Laboratory Medicine have discovered a new way to deliver a protein that helps develop cells that convert fat into energy. The research might have a profound significance for how obese individuals and patients with Type 2 diabetes are treated in the future. Read more.
Published: May 14th, 2014
The UF Health Wound Care and Hyperbaric Center at Magnolia Park offers wound patients with diabetes, obesity and other chronic conditions with wounds that are slow to heal access to state-of-the-art technology and treatment options. In addition to improving the quality of life to those afflicted with chronic wounds, the new center will provide outstanding outpatient care within the UF Health network. For more information, call 352-265-4450.
Published: May 8th, 2014
Diabetes investigators at UF Health are seeking participants for a pharmaceutical research study of 1 and up to 3 years to test an investigational new drug for the treatment of Type 1 diabetes. We are looking for males and females between the ages of 18 and 35 who have been diagnosed with Type 1 diabetes within the past 8 weeks. Enrolled participants will receive payment compensation for their time and travel during the study. Learn more.
Published: April 9th, 2014
A new study in Healthy Women suggests that consuming high levels of flavonoids, including compounds found in berries, tea, grapes, and wine, could potentially lower the risk of type 2 diabetes. The compounds responsible for the red or blue color of berries and other fruits and vegetables — anthocyanins — can improve the way we handle glucose and insulin and also reduce inflammation, a risk factor for heart disease and diabetes.